The Net Margin of Xvivo Perfusion AB (XVIVO.ST) is 20.94%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | 20.94% |
| 2023-12-31 | 15.37% |
| 2022-12-31 | 4.44% |
| 2021-12-31 | 3.15% |
| 2020-12-31 | -24.32% |
| 2019-12-31 | 2.24% |
| 2018-12-31 | 6.75% |
| 2017-12-31 | 4.22% |
| 2016-12-31 | 1.09% |
| 2015-12-31 | 4.27% |